The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SEQUOIA 5-year follow-up in arm C: Frontline zanubrutinib monotherapy in patients with del(17p) and treatment-naive chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL).
 
Constantine Tam
Honoraria - Abbvie; Beigene; Janssen-Cilag; Loxo/Lilly; Roche/Genentech
Consulting or Advisory Role - Abbvie; BeiGene; Janssen; Loxo; Roche
Research Funding - Abbvie (Inst); BeiGene (Inst); Janssen-Cilag (Inst)
 
Paolo Ghia
Honoraria - Abbvie; AstraZeneca; BeiGene; Galapagos NV; Gilead Sciences; Janssen Oncology; Juno/Celgene/Bristol-Myers Squibb; Lilly; MSD; Roche
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene/Juno; Galapagos NV; Janssen; Lilly; MSD; Roche
Research Funding - Abbvie; AstraZeneca; Bristol-Myers Squibb/Celgene/Juno (Inst); Janssen Oncology; Lilly
 
Mazyar Shadman
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; BeiGene; Bristol-Myers Squibb/Celgene; Fate therapeutics; Genentech; Genmab; Kite, a Gilead company; Lilly; Merck; MorphoSys; Nurix; Pharmacyclics; Regeneron
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); BeiGene (Inst); Bristol-Myers Squibb/Celgene; Celgene (Inst); Genentech (Inst); Genmab (Inst); Merck (Inst); MustangBio (Inst); Pharmacyclics (Inst); Sunesis Pharmaceuticals (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Talha Munir
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; AstraZeneca; BeiGene; Janssen-Cilag; Lilly; Roche; SOBI
Speakers' Bureau - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Gilead Sciences; Janssen-Cilag; SOBI
Travel, Accommodations, Expenses - Abbvie; Alexion Pharmaceuticals; AstraZeneca; Janssen-Cilag
 
Stephen Opat
Employment - Monash Health
Honoraria - AbbVie, AstraZeneca, Gilead, Janssen, Merck, Roche, Takeda
Consulting or Advisory Role - AbbVie, AstraZeneca, BeiGene, Janssen, Novartis
Research Funding - AbbVie, AstraZeneca, BeiGene, Gilead, Janssen, Novartis, Pharmacyclics, Roche, Takeda
Expert Testimony - AbbVie, AstraZeneca, BeiGene, Janssen, Novartis
 
Patricia Walker
No Relationships to Disclose
 
Masa Lasica
Honoraria - AbbVie; Janssen
Consulting or Advisory Role - AbbVie; Janssen; Recordati; Sobi
 
Ian Flinn
Consulting or Advisory Role - Abbvie; BeiGene; Genentech; Genmab; Kite/Gilead; Vincerx Pharma
Research Funding - 2seventy bio (Inst); Abbvie (Inst); AstraZeneca (Inst); BeiGene (Inst); Bristol Myers Squibb (Inst); Celgene (Inst); City of Hope (Inst); Epizyme (Inst); Fate Therapeutics; Genentech (Inst); Gilead Sciences (Inst); IGM Biosciences (Inst); Incyte (Inst); Innocare (Inst); Janssen (Inst); Kite, a Gilead company (Inst); Loxo (Inst); Marker Therapeutics (Inst); Merck (Inst); MorphoSys (Inst); Myeloid Therapeutics (Inst); Myeloid Therapeutics (Inst); Novartis (Inst); Novartis (Inst); Novartis (Inst); Nurix (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); TG Therapeutics (Inst); Vincerx Pharma (Inst)
 
Tian Tian
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
 
Stephanie Agresti
Employment - BeOne Medicines Ltd
Stock and Other Ownership Interests - BeOne Medicines Ltd
Travel, Accommodations, Expenses - BeOne Medicines Ltd
 
Jamie Hirata
Employment - BeOne Medicines Ltd; Genentech
Stock and Other Ownership Interests - BeOne Medicines Ltd; Roche
 
Jennifer Brown
Consulting or Advisory Role - Abbvie; Acerta/Astra-Zeneca; Alloplex Biotherapeutics Inc; BeiGene; Bristol-Myers Squibb; EcoR1 Capital; Galapagos NV; Genentech/Roche; Grifols Worldwide Operations; InnoCare Pharma Inc; Kite, a Gilead company; Loxo/Lilly; Magnet Biomedicine; Merck; Numab; Pharmacyclics
Research Funding - BeiGene (Inst); Gilead Sciences (Inst); iOnctura; Loxo/Lilly (Inst); MEI Pharma (Inst); TG Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Receives royalties from UpToDate associated with authorship of articles.
Other Relationship - Serves on the Data Safety Monitoring Board for Grifols Therapeutics